Stage Capital has sold Stiplastics Healthcaring to Mérieux Développement and GIMV
Lincoln International (“Lincoln”) is pleased to announce that it represented Stage Capital (“Stage”) in the sale of the STI Group to Mérieux Développement and GIMV. Terms of the transaction were not disclosed.
STI Group is a fast-growing developer and manufacturer of plastic medical devices for the healthcare industry. Stage has sold its 92.5% stake in the business, having transformed a diversified moulding company acquired in 2013 into a pure-play medical devices business that is very well positioned to become a key player in the connected devices market.
“The Mérieux Développement – Gimv consortium is an ideal tandem that will allow Stiplastics Healthcaring to grow further and accelerate its development. They bring to the table health sector specialists as well as substantial financial resources, which are perfectly suited to support the Group’s growth challenges,” explained Jérôme Empereur, Stiplastics Healthcaring’s Chairman-CEO.
Lincoln acted as the exclusive financial advisor to Stage, working closely with the management team and shareholders throughout the sale process. Lincoln senior-level attention and buyer knowledge and ability to assess and present recent new business wins to potential investors were instrumental in driving an attractive outcome for shareholders.
Meet our Senior Team
View More Transactions in Healthcare
Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.